FDA recall Z-2830-2020

Pharmaceutical Innovations, Inc. · Class II · device

Product

Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) - Product Usage: A gel pad for use on woman s areola during an ultrasound examination. Its primary purpose is for patient comfort over the loose gel and helps with nipple location during the scan, making the areola location easier to identify.

Reason for recall

The firm registered the product as a Class I device, but has since been informed by FDA that the device is not Class I and requires a 510(k) submission.

Distribution

US Nationwide distribution including in the state of Nevada.

Key facts

Status
Terminated
Initiation date
2020-08-13
Report date
2020-08-26
Termination date
2021-09-16
Voluntary/Mandated
Voluntary: Firm initiated
Location
Newark, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2830-2020